
Defining Alzheimer’s Disease and MCI Management in the Modern Era
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
-
Narrated by:
-
By:
About this listen
In this episode, Drs. Sabbagh and Isaacson discuss how to best approach Alzheimer’s disease (AD) and mild cognitive impairment (MCI) in clinical practice, including accurately diagnosing patients and optimizing treatment in terms of patient preferences and reimbursement options. The full episode covers:
- Defining AD and MCI and their clinical presentation
- How to diagnose AD vs MCI
- Reimbursement landscape for current diagnosing and monitoring tools
- Precision medicine’s evolving role in diagnosing and treating patients with AD and/or MCI
Presenters:
Marwan Sabbagh, MD
Professor of Neurology
Alzheimer’s and Memory Disorders Division
Department of Neurology
Barrow Neurological Institute
Phoenix, Arizona
Richard Isaacson MD
Director of the Institute for Neurodegenerative Diseases
Florida
No reviews yet